A soluble vaccinia virus protein that binds chemokines

Details for Australian Patent Application No. 2002301315 (hide)

Owner Oxxon Therapeutics Limited

Inventors Ng, Aylwin; Smith, Geoffrey

Agent Watermark

Pub. Number AU-B-2002301315

Parent 63020

Filing date 3 October 2002

Wipo publication date 27 February 2003

Acceptance publication date 20 July 2006

International Classifications

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C07K 14/07 (2006.01) Peptides having more than 20 amino acids

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-B-2002301315

21 July 2005 Assignment before Grant

  Isis Innovation Limited The application has been assigned to Oxxon Therapeutics Limited

20 July 2006 Application Accepted

  Published as AU-B-2002301315

16 November 2006 Standard Patent Sealed

16 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002301316-Knitted fabric

2002301314-Game Display With Enhanced Entertainment Values